Saha, SChant, DWelham, JMcGrath, JA systematic review of the prevalence of schizophrenia. Plos Med 2005;2:e141.
Gao, SHu, ZCheng, JZhou, WXu, YXie, S, et al.Impact of catechol-O-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance. Clin Biochem 2012; 45: 787–792.
Cheng, JWang, YZhou, KWang, LLi, JZhuang, Q, et al.Male-specific association between dopamine receptor D4 gene methylation and schizophrenia. Plos One 2014;9:e89128.
Lindamer, LALohr, JBHarris, MJJeste, DVGender, estrogen, and schizophrenia. Psychopharmacol Bull 1997; 33: 221–228.
Goldstein, JMCherkerzian, STsuang, MTPetryshen, TLSex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am J Med Genet A 2013;162B:698–710.
Abel, KMDrake, RGoldstein, JMSex differences in schizophrenia. Int Rev Psychiatry 2010; 22: 417–428.
Meyer-Lindenberg, AKohn, PDKolachana, BKippenhan, SMcInerney-Leo, ANussbaum, R, et al.Midbrain dopamine and prefrontal function in humans: interaction and modulation by COMT genotype. Nat Neurosci 2005; 8: 594–596.
Walton, ELiu, JHass, JWhite, TScholz, MRoessner, V, et al.MB-COMT promoter DNA methylation is associated with working-memory processing in schizophrenia patients and healthy controls. Epigenetics 2014; 9: 1101–1107.
Swift-Scanlan, TSmith, CTBardowell, SABoettiger, CAComprehensive interrogation of CpG island methylation in the gene encoding COMT, a key estrogen and catecholamine regulator. BMC Med Genom 2014;7:5.
Dempster, ELMill, JCraig, IWCollier, DAThe quantification of COMT mRNA in post mortem cerebellum tissue: diagnosis, genotype, methylation and expression. BMC Med Genet 2006;7:10.
Nestler, EJPena, CJKundakovic, MMitchell, AAkbarian, SEpigenetic basis of mental illness. Neuroscientist 2016; 22(5): 447–463.
Nishioka, MBundo, MKasai, KIwamoto, KDNA methylation in schizophrenia: progress and challenges of epigenetic studies. Genome Med 2012; 4(12): 96
Dai, DCheng, JZhou, KLv, YZhuang, QZheng, R, et al.Significant association between DRD3 gene body methylation and schizophrenia. Psychiatr Res 2014; 220: 772–777.
Lott, SABurghardt, PRBurghardt, KJBly, MJGrove, TBEllingrod, VLThe influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia. Pharmacogenomics J 2013; 13: 264–271.
Nohesara, SGhadirivasfi, MMostafavi, SEskandari, MRAhmadkhaniha, HThiagalingam, S, et al.DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder. J Psychiatr Res 2011; 45: 1432–1438.
Abdolmaleky, HMCheng, KHFaraone, SVWilcox, MGlatt, SJGao, F, et al.Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum Mol Genet 2006; 15: 3132–3145.
Smith, ARSmith, RGCondliffe, DHannon, ESchalkwyk, LMill, J, et al.Increased DNA methylation near TREM2 is consistently seen in the superior temporal gyrus in Alzheimer's disease brain. Neurobiol Aging 2016; 47: 35–40.
Zhou, JHuang, YHuang, RSWang, FXu, LLe, Y, et al.A case-control study provides evidence of association for a common SNP rs974819 in PDGFD to coronary heart disease and suggests a sex-dependent effect. Thromb Res 2012; 130: 602–606.
Bachtiar, ISantoso, JMAtmanegara, BGani, RAHasan, ILesmana, LA, et al.Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma. Clin Chim Acta 2009; 399: 97–101.
Zhou, HGuo, JMLou, YRZhang, XJZhong, FDJiang, Z, et al.Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J Mol Med 2010; 88: 709–717.
Liao, QWang, YCheng, JDai, DZhou, XZhang, Y, et al.DNA methylation patterns of protein coding genes and long noncoding RNAs in female schizophrenic patients. Eur J Med Genet 2015; 58: 95–104.
Liao, QWang, YCheng, JDai, DZhou, XZhang, Y, et al.DNA methylation patterns of protein-coding genes and long non-coding RNAs in males with schizophrenia. Mol Med Rep 2015
Kinoshita, MNumata, STajima, AShimodera, SOno, SImamura, A, et al.DNA methylation signatures of peripheral leukocytes in schizophrenia. Neuromol Med 2013; 15: 95–101.
Xu, QMa, JZPayne, TJLi, MDDetermination of methylated CpG sites in the promoter region of catechol-O-methyltransferase (COMT) and their involvement in the etiology of tobacco smoking. Front Psychiatr 2010;1:16.
Murphy, BCO’Reilly, RLSingh, SMSite-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am J Med Genet A 2005;133B:37–42.
Mill, JTang, TKaminsky, ZKhare, TYazdanpanah, SBouchard, L, et al.Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am J Hum Genet 2008; 82: 696–711.
Melas, PARogdaki, MOsby, USchalling, MLavebratt, CEkstrom, TJEpigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset. FASEB J 2012; 26: 2712–2718.
Mellios, NGaldzicka, MGinns, EBaker, SPRogaev, EXu, J, et al.Gender-specific reduction of estrogen-sensitive small RNA, miR-30b, in subjects with schizophrenia. Schizophr Bull 2012; 38: 433–443.
Lai, CYYu, SLHsieh, MHChen, CHChen, HYWen, CC, et al.MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia. Plos One 2011;6:e21635.
Kinoshita, MNumata, STajima, AShimodera, SImoto, IOhmori, TPlasma total homocysteine is associated with DNA methylation in patients with schizophrenia. Epigenetics 2013; 8: 584–590.
Guidotti, AAuta, JChen, YDavis, JMDong, EGavin, DP, et al.Epigenetic GABAergic targets in schizophrenia and bipolar disorder. Neuropharmacology 2011; 60: 1007–1016.
Ernst, JKheradpour, PMikkelsen, TSShoresh, NWard, LDEpstein, CB, et al.Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011; 473: 43–49.
Gerstein, MBKundaje, AHariharan, MLandt, SGYan, KKCheng, C, et al.Architecture of the human regulatory network derived from ENCODE data. Nature 2012; 489: 91–100.